Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections
Authors
Keywords
Minocycline, Colistin, Bloodstream Infection, Polymyxin, Tigecycline
Journal
DRUGS
Volume 74, Issue 12, Pages 1315-1333
Publisher
Springer Nature
Online
2014-08-04
DOI
10.1007/s40265-014-0267-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
- (2014) S. W. S. Yapa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*
- (2014) Hao-Yuan Lee et al. CRITICAL CARE MEDICINE
- Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
- (2014) A. Batirel et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii
- (2014) Irene Galani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical Outcomes
- (2013) Teena Chopra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unique Structural Modifications Are Present in the Lipopolysaccharide from Colistin-Resistant Strains of Acinetobacter baumannii
- (2013) Mark R. Pelletier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Vancomycin-Containing Regimens against Colistin-Resistant Acinetobacter baumannii Clinical Strains
- (2013) Jessica A. O'Hara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii
- (2013) C. Rumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii
- (2013) Paul G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria
- (2013) Nicola Petrosillo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
- (2013) José Garnacho-Montero et al. CHEMOTHERAPY
- Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
- (2013) Mario Tumbarello et al. CHEST
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use
- (2013) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
- (2013) Darowan S. Akajagbor et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis
- (2013) E.V. Lemos et al. CLINICAL MICROBIOLOGY AND INFECTION
- The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam
- (2013) MS Oliveira et al. Clinics
- Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
- (2013) Y.-T. Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013
- (2013) J Decousser et al. Eurosurveillance
- Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
- (2013) Jason M Pogue et al. Expert Review of Anti-Infective Therapy
- Carbapenem resistance inAcinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies
- (2013) Iain Abbott et al. Expert Review of Anti-Infective Therapy
- Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment
- (2013) E. S. Snitkin et al. GENOME RESEARCH
- A Multicenter Case-Case Control Study for Risk Factors and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2013) Tat Ming Ng et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
- (2013) Michael Hornsey et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review
- (2013) Ilias Karaiskos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- (2013) L. Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections
- (2013) Emil Lesho et al. JOURNAL OF INFECTIOUS DISEASES
- Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
- (2013) Gerald A Denys et al. Annals of Clinical Microbiology and Antimicrobials
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate
- (2012) Roberto Imberti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumanniiinfection
- (2012) Erika Ferraz de Gouvêa et al. BMC INFECTIOUS DISEASES
- Impact of Appropriate Antimicrobial Therapy on Mortality Associated With Acinetobacter baumannii Bacteremia: Relation to Severity of Infection
- (2012) Y.-T. Lee et al. CLINICAL INFECTIOUS DISEASES
- Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)
- (2012) X. Schleicher et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010
- (2012) Anne Marie Queenan et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
- (2012) Phillip J. Bergen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dissemination of ceftazidime-resistant Acinetobacter baumannii clonal complex 92 in Korea
- (2012) Y. Lee et al. JOURNAL OF APPLIED MICROBIOLOGY
- Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species
- (2012) Yuichi Kouyama et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Risk Factors for Occurrence and 30-Day Mortality for Carbapenem-Resistant Acinetobacter baumannii Bacteremia in an Intensive Care Unit
- (2012) Song Yee Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
- (2012) Youn Jeong Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins
- (2012) B. S. Lopes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- In Vitro Activity of Minocycline Alone and in Combination with Cefoperazone-Sulbactam Against Carbapenem-Resistant Acinetobacter baumannii
- (2012) Guangsheng Pei et al. Microbial Drug Resistance
- Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
- (2012) Ryan K. Shields et al. PLoS One
- Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: Susceptibility and clinical outcome
- (2012) Nak-Hyun Kim et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream Infections
- (2011) John S. Esterly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime
- (2011) Guo-Bao Tian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoEfficacy of Glycopeptide-Colistin Combination Therapies in aGalleria mellonellaModel ofAcinetobacter baumanniiInfection
- (2011) M. Hornsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
- (2011) Luis A. Arroyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
- (2011) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients
- (2011) Wang Liang et al. BMC INFECTIOUS DISEASES
- Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study
- (2011) S.-C. Kuo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
- (2011) Maria Giannouli et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of NDM-1-producing Acinetobacter baumannii in China
- (2011) Y. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
- (2011) Jennifer M. Adams-Haduch et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States
- (2011) Hilmar Wisplinghoff et al. JOURNAL OF INFECTION
- Trends in Antimicrobial Resistance of Acinetobacter baumannii Isolates from a Metropolitan Detroit Health System
- (2010) T. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
- (2010) S. T. Micek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
- (2010) M. E. Pachon-Ibanez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
- (2010) S. Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia
- (2010) C. Pichardo et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008
- (2010) Alexander J. Kallen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak
- (2010) L. Silvia Munoz-Price et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation
- (2010) D. E. Nix et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex
- (2010) K. S. Akers et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Acinetobacter baumannii 2002–2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States
- (2010) Robertino M. Mera et al. Microbial Drug Resistance
- Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia
- (2010) Jeannie D. Chan et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Penetration of Colistin into Cerebrospinal Fluid
- (2009) S. L. Markantonis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overexpression of the Naturally Occurring blaOXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence ISAba9
- (2009) S. Figueiredo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection of KPC in Acinetobacter spp. in Puerto Rico
- (2009) I. E. Robledo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumannii
- (2009) C. Moubareck et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mortality Associated with Acinetobacter baumannii Complex Bacteremia among Patients with War-Related Trauma
- (2009) Grace Kang et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections
- (2009) Ayşe Erbay et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania
- (2008) J. M. Adams-Haduch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline
- (2008) K. B. Anthony et al. CLINICAL INFECTIOUS DISEASES
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
- (2008) M. E. Falagas et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
- (2008) Alicia I. Hidron et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
- (2008) M. S. Oliveira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2008) Alex P. Betrosian et al. JOURNAL OF INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started